122 related articles for article (PubMed ID: 18931719)
21. Mechanical stretch induces endothelial nitric oxide synthase gene expression in neonatal rat cardiomyocytes.
Cheng TH; Chen JJ; Shih NL; Lin JW; Liu JC; Chen YL; Chen CH; Chen JJ
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):559-66. PubMed ID: 19673940
[TBL] [Abstract][Full Text] [Related]
22. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
23. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
24. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes.
Qin J; Liu ZX
Acta Pharmacol Sin; 2006 Sep; 27(9):1159-64. PubMed ID: 16923336
[TBL] [Abstract][Full Text] [Related]
25. [Angiotensin II induced cardiac hypertrophy is blocked by PTEN via suppressing Ca2+/Calcineurin pathway].
Yu LJ; Zhu SJ; Zhou YZ; Wang J; Tian Y; Zhu ZM
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):541-5. PubMed ID: 16842674
[TBL] [Abstract][Full Text] [Related]
26. [Atorvastatin attenuates parathyroid hormone 1-34 induced cardiomyocytes hypertrophy through downregulating K-Ras-ERK1/2 pathway].
Liu XG; Miao N; Sui MS; Mu SH; Zhao SL; Xie RJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1051-5. PubMed ID: 23363723
[TBL] [Abstract][Full Text] [Related]
27. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.
Dong B; Xue R; Sun Y; Dong Y; Liu C
Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371
[TBL] [Abstract][Full Text] [Related]
28. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
Huang Q; Huang J; Zeng Z; Luo J; Liu P; Chen S; Liu B; Pan X; Zang L; Zhou S
Life Sci; 2015 Mar; 124():41-9. PubMed ID: 25636810
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated overexpression of cardiac troponin I-interacting kinase promotes cardiomyocyte hypertrophy.
Wang L; Wang H; Ye J; Xu RX; Song L; Shi N; Zhang YW; Chen X; Meng XM
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):278-84. PubMed ID: 21314842
[TBL] [Abstract][Full Text] [Related]
30. [Effect of NOS and PTEN on cardiomyocyte hypertrophy induced by angiotensin II].
Wu Y; Hu YE
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Feb; 21(1):41-5. PubMed ID: 21166162
[TBL] [Abstract][Full Text] [Related]
31. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes.
Zobel C; Kassiri Z; Nguyen TT; Meng Y; Backx PH
Circulation; 2002 Oct; 106(18):2385-91. PubMed ID: 12403671
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of α-enolase protects cardiomyocytes from phenylephrine-induced hypertrophy.
Gao S; Liu XP; Wei LH; Lu J; Liu P
Can J Physiol Pharmacol; 2018 Apr; 96(4):352-358. PubMed ID: 28910549
[TBL] [Abstract][Full Text] [Related]
33. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2.
Soriano FX; Liesa M; Bach D; Chan DC; Palacín M; Zorzano A
Diabetes; 2006 Jun; 55(6):1783-91. PubMed ID: 16731843
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes.
Liu Y; Wang Z; Xiao W
Mol Med Rep; 2016 Sep; 14(3):2860-6. PubMed ID: 27485101
[TBL] [Abstract][Full Text] [Related]
36. Homocysteine restricts copper availability leading to suppression of cytochrome C oxidase activity in phenylephrine-treated cardiomyocytes.
Zuo X; Dong D; Sun M; Xie H; Kang YJ
PLoS One; 2013; 8(6):e67549. PubMed ID: 23818984
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor delta regulates mitofusin 2 expression in the heart.
Li Y; Yin R; Liu J; Wang P; Wu S; Luo J; Zhelyabovska O; Yang Q
J Mol Cell Cardiol; 2009 Jun; 46(6):876-82. PubMed ID: 19265701
[TBL] [Abstract][Full Text] [Related]
38. Effects of tanshinone VI on the hypertrophy of cardiac myocytes and fibrosis of cardiac fibroblasts of neonatal rats.
Maki T; Kawahara Y; Tanonaka K; Yagi A; Takeo S
Planta Med; 2002 Dec; 68(12):1103-7. PubMed ID: 12494338
[TBL] [Abstract][Full Text] [Related]
39. Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes.
You J; Yue Z; Chen S; Chen Y; Lu X; Zhang X; Shen P; Li J; Han Q; Li Z; Liu P
Acta Physiol (Oxf); 2017 May; 220(1):58-71. PubMed ID: 27614093
[TBL] [Abstract][Full Text] [Related]
40. A20 is dynamically regulated in the heart and inhibits the hypertrophic response.
Cook SA; Novikov MS; Ahn Y; Matsui T; Rosenzweig A
Circulation; 2003 Aug; 108(6):664-7. PubMed ID: 12900338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
